Publications by authors named "Imaeda T"

Article Synopsis
  • A nationwide study in Japan analyzed the relationship between intensive care unit (ICU) case volume and outcomes for sepsis patients using data from 2010 to 2017.
  • The study found that patients in higher-volume ICUs had significantly lower in-hospital mortality rates compared to those in lower-volume ICUs, indicating that more experience in treating sepsis correlates with better patient outcomes.
  • However, higher-volume ICUs also incurred higher daily medical costs, suggesting a trade-off between cost and quality of care, especially for patients requiring advanced therapies like mechanical ventilation.
View Article and Find Full Text PDF

Few population-based studies including younger adults have examined the potential of olfactory function tests to capture the degree of atrophy in memory-associated brain regions, which cannot be adequately explained by cognitive function tests screening for cognitive impairment. This population-based study investigated associations between high-resolution olfactory test data with few odours and grey matter volumes (GMVs) of the left and right hippocampi, amygdala, parahippocampi, and olfactory cortex, while accounting for differences in cognitive decline, in 1444 participants (aged 31-91 years). Regression analyses included intracranial volume (ICV)-normalised GMVs of eight memory-related regions as objective variables and age, sex, education duration, smoking history, olfaction test score, and the Montreal Cognitive Assessment-Japanese version (MoCA-J) score as explanatory variables.

View Article and Find Full Text PDF
Article Synopsis
  • - A study analyzed over 73 million hospitalized patients in Japan from 2010 to 2019 to explore the prevalence of community-acquired infections (CAI) and nosocomial infections (NI), finding increases in both types of infections, particularly among those aged 85 and older.
  • - The research indicated that 9.7% of patients had CAI and 4.7% had NI, with NI having a higher in-hospital mortality rate (14.5% vs. 8.3%) and resulting in longer hospital stays and greater medical costs.
  • - Despite the overall decline in mortality rates for both infections over the years, the data highlights the significant impact of NI on older patients, undersc
View Article and Find Full Text PDF

Background: Following marketing authorization in Japan, for almost all new drugs or new indications, postmarketing studies (PMS) are a regulatory requirement. These PMS focus on accrual of a defined number of cases with data being collected for a predetermined period after approval to confirm efficacy/effectiveness, safety, and quality in the Japanese population. In contrast to other regions where PMS are only required to address a specific scientific uncertainty, in Japan, PMS are often required regardless of any specific scientific uncertainty, and therefore, their scientific value is unclear.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to analyze the initial antimicrobial treatment options for patients with community-onset sepsis in Japan, using a large dataset from a medical reimbursement system.
  • Over 1.1 million patients were examined, revealing that third-generation cephalosporins and carbapenem were the most commonly prescribed antimicrobials, with only a small percentage receiving treatment for methicillin-resistant infections.
  • The findings indicated that while many patients received antipseudomonal agents, combination therapies for drug-resistant bacteria were infrequently used, suggesting a potential gap in effective treatment strategies.
View Article and Find Full Text PDF
Article Synopsis
  • Hospitals that spend more on medical resources show lower mortality rates for sepsis patients than those that spend less, according to a study analyzing data from 997 hospitals between 2010 and 2017.
  • The study found that in the highest spending quartile, the in-hospital mortality rate was significantly lower (13.2%) compared to the lowest quartile (15.7%), indicating a strong relationship between spending and patient survival.
  • Additionally, hospitals with higher spending also had higher effective costs per survivor, suggesting that increased expenditure leads not only to better outcomes but also costs more per patient saved, especially in smaller or medium-sized hospitals.
View Article and Find Full Text PDF

Sepsis is the leading cause of death worldwide. Considering regional variations in the characteristics of patients with sepsis, a better understanding of the epidemiology in Japan will lead to further development of strategies for the prevention and treatment of sepsis. To investigate the epidemiology of sepsis, we conducted a systematic literature review of PubMed between 2003 and January 2023.

View Article and Find Full Text PDF

Background: Olfactory function decline has recently been reported to be associated with a risk of cognitive impairment. Few population-based studies have included younger adults when examining the association between olfactory test data with multiple odor intensities and suspected cognitive impairment.

Objective: We investigated the association between high-resolution olfactory test data with fewer odors and suspected cognitive impairments.

View Article and Find Full Text PDF

Background And Aims: The Children's Depression Rating Scale-Revised (CDRS-R) score has been widely used to assess the severity of major depression in children and adolescents; however, the clinical implications of changes in the CDRS-R score remain unclear. We evaluated these clinical implications by assessing the relationship between changes in the CDRS-R score and changes in the Clinical Global Impression of Improvement (CGI-I), in clinical research on major depression.

Methods: We used data from four clinical trials involving two antidepressants and evaluated the relationship between CDRS-R score changes and the CGI-I score using the equipercentile linking method.

View Article and Find Full Text PDF

Introduction: In the current era of the severe acute respiratory syndrome-coronavirus-2 epidemic, the need for respiratory care, including mechanical ventilatory (MV) management, has increased. However, there are no well-developed educational strategies for training medical personnel dealing with respiratory care in MV management.

Methods: A novel mixed-methods hands-on seminar for learning MV management was conducted for the residents at Chiba University Hospital in March 2022.

View Article and Find Full Text PDF

Purpose: We examined the inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by a nitrogen-doped titanium dioxide (N-TiO) visible-light photocatalyst that was activated via light irradiation in the natural environment and was safe for human use as a coating material.

Methods: The photocatalytic activity of glass slides coated with three types of N-TiO without metal or loaded with copper or silver and copper was investigated by measuring acetaldehyde degradation. The titer levels of infectious SARS-CoV-2 were measured using cell culture after exposing photocatalytically active coated glass slides to visible light for up to 60 min.

View Article and Find Full Text PDF

N-Methyl-D-aspartate receptors (NMDARs) are key regulators of synaptic plasticity in the central nervous system. Potentiation of NMDARs containing GluN2A subunit has been recently recognized as a promising therapeutic approach for neurological disorders. We identified a novel series of GluN2A positive allosteric modulator (PAM) with a pyridin-2-one scaffold.

View Article and Find Full Text PDF

With increasing reports of resistance to artemisinins and artemisinin-combination therapies, targeting the proteasome is a promising strategy for antimalarial development. We recently reported a highly selective proteasome inhibitor with anti-malarial activity in the humanized mouse model. To balance the permeability of the series of macrocycles with other drug-like properties, we conducted further structure-activity relationship studies on a biphenyl ether-tethered macrocyclic scaffold.

View Article and Find Full Text PDF
Article Synopsis
  • Sepsis patients often need specialized care in the ICU, but the impact of ICU management on their survival rates is not well studied, prompting researchers to test if ICU admission improves outcomes.
  • A retrospective analysis of data from over 1.1 million sepsis patients in Japan (2010-2017) was conducted, focusing on in-hospital mortality rates between non-ICU and ICU patients, using statistical methods to adjust for differences in patient characteristics.
  • Results showed that the unadjusted in-hospital mortality was slightly higher in the ICU (26.2%) compared to non-ICU (22.5%), but after proper adjustments, the ICU mortality rate (25.8%) was lower than non-ICU
View Article and Find Full Text PDF
Article Synopsis
  • A study analyzed the effects of short (≤7 days) versus long (≥8 days) antibiotic treatment on 28-day mortality in sepsis patients using data from a Japanese claims database between 2010 and 2017.
  • The results indicated that shorter antibiotic courses were associated with significantly lower 28-day mortality rates but higher rates of re-initiated antibiotics.
  • Additionally, patients receiving shorter treatments had fewer antibiotic-free days and lower medical costs compared to those on longer courses.
View Article and Find Full Text PDF

Development of methods for population screening is necessary to improve the efficiency of secondary prevention of diseases. Until now, a common cutoff has been used for all people in the data set. However, if big data for health information can be used to modify individual cutoffs according to background factors, it may avoid wasting medical resources.

View Article and Find Full Text PDF

Background: Sepsis is the leading cause of death worldwide. Although the mortality of sepsis patients has been decreasing over the past decade, the trend of medical costs and cost-effectiveness for sepsis treatment remains insufficiently determined.

Methods: We conducted a retrospective study using the nationwide medical claims database of sepsis patients in Japan between 2010 and 2017.

View Article and Find Full Text PDF

With over 200 million cases and close to half a million deaths each year, malaria is a threat to global health, particularly in developing countries. , the parasite that causes the most severe form of the disease, has developed resistance to all antimalarial drugs. Resistance to the first-line antimalarial artemisinin and to artemisinin combination therapies is widespread in Southeast Asia and is emerging in sub-Saharan Africa.

View Article and Find Full Text PDF

We aimed to identify which of the 17 items comprising the Children's Depression Rating Scale-Revised (CDRS-R) can sensitively capture changes in depression severity. We used data from four studies involving two antidepressants. For each of the 17 CDRS-R items, we conducted item response analyses to identify and evaluate those that reflect changes in depression severity.

View Article and Find Full Text PDF

Background: Trends in the incidence and outcomes of sepsis using a Japanese nationwide database were investigated.

Methods: This was a retrospective cohort study. Adult patients, who had both presumed serious infections and acute organ dysfunction, between 2010 and 2017 were extracted using a combined method of administrative and electronic health record data from the Japanese nationwide medical claim database, which covered 71.

View Article and Find Full Text PDF

Treatment of tuberculosis (TB) currently takes at least 6 months. Latent (Mtb) is phenotypically tolerant to most anti-TB drugs. A key hypothesis is that drugs that kill nonreplicating (NR) Mtb may shorten treatment when used in combination with conventional drugs.

View Article and Find Full Text PDF

Tuberculosis remains a leading cause of death from a single bacterial infection worldwide. Efforts to develop new treatment options call for expansion into an unexplored target space to expand the drug pipeline and bypass resistance to current antibiotics. Lipoamide dehydrogenase is a metabolic and antioxidant enzyme critical for mycobacterial growth and survival in mice.

View Article and Find Full Text PDF